Mirror Biologics, Inc.
PrivateLast Round
Series A
Oct 11, 2022
Total Funding Raised
$30M
Company Overview
Mirror Biologics, Inc. is a biotechnology company that develops and manufactures off-the-shelf, living immune cell immunotherapies for the treatment of metastatic cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirror Biologics, Inc. Comparables
Compare Mirror Biologics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sana Biotechnology | 74% | |
| Artiva | 73% | |
| Atara Biotherapeutics | 73% |
Mirror Biologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 11, 2022 |
Key People
Founding team and executive leadership
Mirror Biologics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bradbury Asset Management (Hong Kong) Limited | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2024
Grew 16% QoQ, from 19 to 22 employees.
- Jul 9, 2024
Grew 18% QoQ, from 17 to 20 employees.
Mirror Biologics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mirror Biologics, Inc.'s valuation, stock price, and market status.
Is Mirror Biologics, Inc. a public or private company?
Mirror Biologics, Inc. is a private company.
What is the current stock price of Mirror Biologics, Inc.?
Mirror Biologics, Inc. is a private company with no public stock price. Caplight tracks Mirror Biologics, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Mirror Biologics, Inc. worth (valuation)?
Valuation information for Mirror Biologics, Inc. is not publicly available.
Can I buy Mirror Biologics, Inc. stock?
Mirror Biologics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mirror Biologics, Inc.'s last funding round?
Mirror Biologics, Inc.'s most recent funding round was Series A on October 11, 2022.
Who are the main investors in Mirror Biologics, Inc.?
Key investors in Mirror Biologics, Inc. include Bradbury Asset Management (Hong Kong) Limited.
Will Mirror Biologics, Inc. IPO soon?
No public IPO plans have been announced for Mirror Biologics, Inc..
How can I track Mirror Biologics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mirror Biologics, Inc.'s secondary market activity and sign up for updates.